Skip to main content
Caplight Logo









AlgenScribe

AlgenScribe

Private
NiceHealthcare & Life Scienceshttps://www.algenscribe.fr/

Last Round

Seed

Nov 22, 2025

Total Funding Raised

$541,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AlgenScribe is a biotechnology company developing a genome editing platform to improve human health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

genome editinggene therapygene editing platformpreclinical biotechCRISPRcell and gene therapyCGThomology-directed repairHDRgene correctionbioproductionmolecular biology toolsrare genetic diseasesindelsR&D partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AlgenScribe Comparables

Compare AlgenScribe with similar companies based on industry and business-model similarity.

AlgenScribe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Integra Therapeutics
81%
Caszyme
74%
Mammoth Biosciences
73%

AlgenScribe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 22, 2025
GrantAug 1, 2024
Pre SeedJun 5, 2023

AlgenScribe Investors

Notable investors and investment history

AlgenScribe investors
InvestorRounds
Agence Nationale de la RechercheGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 590% MoM, from 73 to 504.

  • Nov 22, 2025

    $541K raised in Seed round.

AlgenScribe Filings

Explore SEC and related filing metadata, where available.

AlgenScribe filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AlgenScribe's valuation, stock price, and market status.

Is AlgenScribe a public or private company?

AlgenScribe is a private company.

What is the current stock price of AlgenScribe?

AlgenScribe is a private company with no public stock price. No recent secondary market data is available.

How much is AlgenScribe worth (valuation)?

Valuation information for AlgenScribe is not publicly available.

Can I buy AlgenScribe stock?

AlgenScribe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AlgenScribe's last funding round?

Funding round information for AlgenScribe is not publicly available.

Who are the main investors in AlgenScribe?

Investor information for AlgenScribe is not publicly disclosed.

Will AlgenScribe IPO soon?

No public IPO plans have been announced for AlgenScribe.

How can I track AlgenScribe secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AlgenScribe's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNice
Employee Range1
Year Founded2022
Last FundingNov 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?